# Discovery of Novel Genes Encoding Antimicrobial Peptides from the Pedobacter silvilitoris Genome with Broad-Spectrum Antimicrobial Activity

## TL;DR

Researchers discovered 11 new antimicrobial peptides from Pedobacter silvilitoris that show strong activity against a range of bacteria, including drug-resistant strains.

## Contribution

Identification of 11 novel AMP-encoding genes from P. silvilitoris with broad-spectrum antimicrobial activity.

## Key findings

- The cell-free supernatant from P. silvilitoris inhibited diverse pathogens and caused membrane damage in bacteria.
- Eleven AMP genes (PS_AMP1 to PS_AMP11) were identified and confirmed to have antimicrobial activity against both Gram-negative and Gram-positive bacteria.
- PS_AMP11 was the most effective candidate, showing strong antimicrobial potential.

## Abstract

The rising prevalence of antibiotic-resistant bacteria demands exploration of alternative antimicrobials. Antimicrobial peptides (AMPs) are a promising group of compounds naturally produced by microorganisms and could serve as potent agents against resistant pathogens. In this study, we evaluated the antimicrobial potential of the cell-free supernatant obtained from Pedobacter silvilitoris—a bacterium originally isolated from decomposing wood—and performed comprehensive genomic screening to uncover novel AMP-encoding genes. The supernatant showed strong inhibitory effects against a diverse selection of pathogens. Scanning electron microscopy (SEM) revealed extensive membrane damage, including pore formation in target bacterial cells, suggesting AMP-mediated activity. A genomic analysis identified 11 candidate AMP genes, named PS_AMP1 to PS_AMP11, based on the significant sequence similarity with known AMPs. Transcriptomic profiling further indicated that several candidates are expressed differentially between the logarithmic and stationary growth phases. Functional assays via gene cloning and peptide synthesis confirmed antimicrobial activity against both Gram-stain-negative and Gram-stain-positive bacteria, with PS_AMP11 emerging as the most effective candidate. Our findings demonstrate that AMPs derived from P. silvilitoris hold substantial promise as alternative antimicrobial agents. Nonetheless, additional structural optimizations may be necessary to fine-tune specificity and to reduce potential host toxicity before clinical deployment.